Biotech

All Articles

F 2G rears $100M for 2nd attempt to receive brand new antifungal to market

.After F2G's 1st effort to receive a new training class of antifungal to market was actually hindere...

Moderna targets $1.1 B in R&ampD investing slices, falls 5 plans surrounded by productivity tensions

.Moderna has promised to reduce R&ampD spending through $1.1 billion by 2027. The selection to retra...

Sanofi's $80M bank on Fulcrum dystrophy medication finishes in stage 3 crash

.Only four months after Sanofi bet $80 million in ahead of time cash on Key Therapies' losmapimod, t...

Oncternal equity sinks 60% among unemployments, test firings

.Cancer cells company Oncternal Therapeutics is actually folding all its own medical trials and layi...

Roche is supporting out chances that its injectable excessive weight possibility can at some point illustrate 25% effective weight loss in late-stage test

.Roche is actually holding out chances that its own injectable being overweight prospect can eventua...

Novo Nordisk barrages 'remarkable' effective weight loss result for dual-acting dental drug in very early test

.Novo Nordisk has actually lifted the lid on a period 1 test of its dental amylin and also GLP-1 rec...

AbbVie takes legal action against BeiGene over blood cancer drug secret method

.Only a few brief weeks after succeeding an FDA Fast Track tag for its investigational BTK degrader ...

Lilly delivers one-two strike along with 2nd tranche of favorable data on regular insulin candidate

.Quickly after a good information decline for Eli Lilly's efsitora alfa, the Indianapolis-based prov...

BridgeBio reduces gene therapy budget as scientific data let down

.BridgeBio Pharma is lowering its own gene therapy budget plan and also drawing back from the techni...

GSK surrenders HSV injection wishes after phase 2 neglect, ceding race to Moderna, BioNTech

.GSK's effort to cultivate the 1st vaccination for herpes simplex virus (HSV) has finished in breakd...